BarronsTue, 28 Apr 2026 16:29:00 GMTErasca Stock Sinks 50% in Race for ‘Miracle' Cancer Drug. What's Behind the Historic Sell-Off.ERAS-2.69%
BenzingaTue, 28 Apr 2026 13:19:00 GMTWhy Is Cancer Drug Developer Erasca Stock Plunging On Tuesday?ERAS-2.69%
Seeking AlphaTue, 28 Apr 2026 02:51:36 GMTErasca, Inc. (ERAS) Discusses Preliminary Phase I Data and Differentiation of Pan-RAS Molecular Glue ERAS-0015 TranscriptERAS-2.69%
The Motley FoolThu, 26 Mar 2026 21:44:22 GMTErasca CMO's Direct Stake Hit Zero. Her Options Position Didn'tERAS-2.69%
24/7 Wall StreetMon, 09 Mar 2026 15:17:10 GMTuniQure, Syndax and Erasca Are Drawing Analyst Interest Ahead of Key Drug CatalystsERAS-2.69%
